Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
3.83%
0%
3.83%
6 Months
6.27%
0%
6.27%
1 Year
4.79%
0%
4.79%
2 Years
14.72%
0%
14.72%
3 Years
37.53%
0%
37.53%
4 Years
-22.07%
0%
-22.07%
5 Years
54.09%
0%
54.09%
Virbac SA for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
8.50%
EBIT Growth (5y)
10.75%
EBIT to Interest (avg)
24.65
Debt to EBITDA (avg)
0.10
Net Debt to Equity (avg)
0.13
Sales to Capital Employed (avg)
1.20
Tax Ratio
26.05%
Dividend Payout Ratio
8.36%
Pledged Shares
0
Institutional Holding
0.01%
ROCE (avg)
22.13%
ROE (avg)
16.62%
Valuation key factors
Factor
Value
P/E Ratio
20
Industry P/E
Price to Book Value
2.51
EV to EBIT
14.32
EV to EBITDA
10.92
EV to Capital Employed
2.30
EV to Sales
1.98
PEG Ratio
NA
Dividend Yield
0.46%
ROCE (Latest)
16.02%
ROE (Latest)
12.82%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Sideways
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Bullish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
Mildly Bearish
No Trend
Shareholding Snapshot : Dec 2023
Shareholding Compare (%holding) 
Majority shareholders
Foreign Institutions
Domestic Funds
Held in 0 Schemes (0%)
Foreign Institutions
Held by 1 Foreign Institutions (0.01%)
Strategic Entities with highest holding
Highest Public shareholder
Annual Results Snapshot (Consolidated) - Dec'24
Dec'24
Dec'23
Change(%)
Net Sales
1,397.40
1,246.90
12.07%
Operating Profit (PBDIT) excl Other Income
274.80
219.50
25.19%
Interest
11.10
8.90
24.72%
Exceptional Items
-14.30
5.60
-355.36%
Consolidate Net Profit
145.80
121.10
20.40%
Operating Profit Margin (Excl OI)
155.70%
137.90%
1.78%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2024 is 12.07% vs 2.52% in Dec 2023
Consolidated Net Profit
YoY Growth in year ended Dec 2024 is 20.40% vs -0.16% in Dec 2023
About Virbac SA 
Virbac SA
Pharmaceuticals & Biotechnology
Virbac SA is a France-based veterinarian pharmaceutical company that specializes in the development and production of vaccines and medicines for domestic animals and livestock. Its production centers are located in France, Australia, the United States, Mexico, Vietnam, Brazil and South Africa. Its development efforts focus mainly on formulating drugs designed to prevent or cure certain animal diseases. Its product portfolio encompasses pet medications such as pest control drugs, vaccines, antibiotics, anesthetics, anti-inflammatory drugs, mouth/dental care products, ophthalmologic and dermatological products intended for dogs, cats, horses, birds and rodents, as well as livestock medications including pest control drugs and antibiotics intended for cattle, sheep, pigs and poultry. It also offers food and electronic identification chips for pets.
Company Coordinates 
Company Details
13eme rue LID, Bp 27, Carros Cedex , CARROS None : 06510
Registrar Details






